Frisius MC

Verified siteinfo

The Netherlands Thialfweg 44, 8441 PW Heerenveen, The Netherlands

2 trials recruiting
Chronic lymphocytic leukaemia · Chronic lymphocytic leukaemia recurrent · Chronic lymphocytic leukaemia refractory
Adult patients

About Specializations

Frisius MC in Heerenveen, The Netherlands specialises in clinical trials of conditions such as Chronic lymphocytic leukaemia, Chronic lymphocytic leukaemia recurrent, Chronic lymphocytic leukaemia refractory, Renal cell carcinoma, and other specialisations. This site conducts important research.

Main research areas of the site

Hemic and Lymphatic Diseases

The Dept of Oncology at Frisius MC concentrates on chronic lymphocytic leukemia and small lymphocytic lymphoma, seeking safer dosing options and improved long‑term outcomes for patients with relapsed or refractory disease.

Relapsed or refractory chronic lymphocytic leukemia
Relapsed or refractory small lymphocytic lymphoma

Current studies evaluate alternative cabozantinib dosing schedules to maintain drug exposure while minimizing side effects, and they compare continued venetoclax therapy versus treatment interruption to assess impact on progression‑free survival.

Neoplasms

Research in solid‑tumor oncology focuses on renal cell carcinoma, exploring novel combinations and treatment durations to enhance patient survival.

Renal cell carcinoma

Ongoing trials aim to determine whether extending venetoclax after rituximab improves progression‑free survival, providing valuable data for future therapeutic strategies.

Clinical Trials Concierge